{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T19:58:35Z","timestamp":1767902315918,"version":"3.49.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This work was supported by Shanxi Province traditional Chinese medicine research project","award":["(2023ZYYA017)"],"award-info":[{"award-number":["(2023ZYYA017)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-22188-3","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T13:49:31Z","timestamp":1741873771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Regional insights into the relationship between metabolic associated steatotic liver disease and chronic kidney disease: a socioeconomic perspective on disease correlation"],"prefix":"10.1186","volume":"25","author":[{"given":"Jiang","family":"Bai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"issue":"4","key":"22188_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335\u201347.","journal-title":"Hepatology"},{"issue":"2","key":"22188_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jhep.2024.08.011","volume":"82","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Zelber-Sagi S, Kuglemas C, et al. Association of food insecurity with MASLD prevalence and liver-related mortality. J Hepatol. 2025;82(2):203\u201310. https:\/\/doi.org\/10.1016\/j.jhep.2024.08.011.","journal-title":"J Hepatol."},{"issue":"9","key":"22188_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41581-024-00863-9","volume":"20","author":"NC Chesnaye","year":"2024","unstructured":"Chesnaye NC, Ortiz A, Zoccali C, Stel VS, Jager KJ. The impact of population ageing on the burden of chronic kidney disease. Nat Rev Nephrol. 2024;20(9):569\u201385.","journal-title":"Nat Rev Nephrol"},{"key":"22188_CR4","doi-asserted-by":"publisher","first-page":"155958","DOI":"10.1016\/j.metabol.2024.155958","volume":"158","author":"P Danpanichkul","year":"2024","unstructured":"Danpanichkul P, et al. Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019. Metabolism. 2024;158:155958.","journal-title":"Metabolism"},{"issue":"2","key":"22188_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000534071","volume":"148","author":"M Ying","year":"2024","unstructured":"Ying M, Shao X, Qin H, Yin P, Lin Y, Wu J, Ren J, Zheng Y. Disease Burden and Epidemiological Trends of Chronic Kidney Disease at the Global, Regional, National Levels from 1990 to 2019. Nephron. 2024;148(2):113\u201323.","journal-title":"Nephron"},{"issue":"5","key":"22188_CR6","doi-asserted-by":"publisher","first-page":"e307","DOI":"10.1016\/S2214-109X(16)00071-1","volume":"4","author":"B Ene-Iordache","year":"2016","unstructured":"Ene-Iordache B, et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health. 2016;4(5):e307\u201319.","journal-title":"Lancet Glob Health"},{"issue":"3","key":"22188_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.kint.2018.04.011","volume":"94","author":"Y Xie","year":"2018","unstructured":"Xie Y, et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94(3):567\u201381.","journal-title":"Kidney Int"},{"issue":"4","key":"22188_CR8","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.jhep.2021.10.025","volume":"76","author":"JV Lazarus","year":"2022","unstructured":"Lazarus JV, et al. The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge? J Hepatol. 2022;76(4):771\u201380.","journal-title":"J Hepatol"},{"issue":"6","key":"22188_CR9","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S2468-1253(22)00008-5","volume":"7","author":"LA Diaz","year":"2022","unstructured":"Diaz LA, et al. The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas. Lancet Gastroenterol Hepatol. 2022;7(6):552\u20139.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"22188_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/gutjnl-2020-323082","volume":"71","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, et al. Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis. Gut. 2022;71(1):156\u201362.","journal-title":"Gut"},{"issue":"4","key":"22188_CR11","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","volume":"72","author":"CD Byrne","year":"2020","unstructured":"Byrne CD, Targher G. NAFLD as a driver of chronic kidney disease. J Hepatol. 2020;72(4):785\u2013801.","journal-title":"J Hepatol"},{"issue":"1","key":"22188_CR12","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1038\/s41598-023-27762-6","volume":"13","author":"SY Kwon","year":"2023","unstructured":"Kwon SY, et al. MAFLD and NAFLD in the prediction of incident chronic kidney disease. Sci Rep. 2023;13(1):1796.","journal-title":"Sci Rep"},{"issue":"1","key":"22188_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/s12885-024-12176-y","volume":"24","author":"Z Maleki","year":"2024","unstructured":"Maleki Z, Hassanzadeh J, Ghaem H. Correlation between socioeconomic indices and epidemiological indices of thyroid cancer from 1990 to 2019 year: a global ecologic study. BMC Cancer. 2024;24(1):467.","journal-title":"BMC Cancer"},{"key":"22188_CR14","doi-asserted-by":"publisher","unstructured":"Jiang CY, Han K, Yang F, et al. Global, regional, and national prevalence of hearing loss from 1990 to 2019: A trend and health inequality analyses based on the Global Burden of Disease Study 2019. Ageing Res Rev. 2023;92:102124. https:\/\/doi.org\/10.1016\/j.arr.2023.102124.","DOI":"10.1016\/j.arr.2023.102124"},{"key":"22188_CR15","doi-asserted-by":"publisher","unstructured":"GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203\u201334. https:\/\/doi.org\/10.1016\/S0140-6736(23)01301-6.","DOI":"10.1016\/S0140-6736(23)01301-6"},{"key":"22188_CR16","doi-asserted-by":"publisher","unstructured":"GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2162\u2013203. https:\/\/doi.org\/10.1016\/S0140-6736(24)00933-4.","DOI":"10.1016\/S0140-6736(24)00933-4"},{"key":"22188_CR17","unstructured":"Country comparisons- median age, central intelligence agency (CIA) https:\/\/www.cia.gov\/the-world-factbook\/field\/median-age\/country-comparison\/ Accessed September 5, 2024"},{"key":"22188_CR18","doi-asserted-by":"publisher","unstructured":"GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2100\u201332. https:\/\/doi.org\/10.1016\/S0140-6736(24)00367-2.","DOI":"10.1016\/S0140-6736(24)00367-2"},{"key":"22188_CR19","doi-asserted-by":"publisher","first-page":"155999","DOI":"10.1016\/j.metabol.2024.155999","volume":"160","author":"H Zhang","year":"2024","unstructured":"Zhang H, et al. Global burden of metabolic diseases, 1990\u20132021. Metabolism. 2024;160:155999.","journal-title":"Metabolism"},{"issue":"1","key":"22188_CR20","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1186\/s12889-024-20445-5","volume":"24","author":"O Al Ta'ani","year":"2024","unstructured":"Al Ta\u2019ani O, Aleyadeh W, Al-Ajlouni Y, et al. The burden of cirrhosis and other chronic liver disease in the middle east and North Africa (MENA) region over three decades. BMC Public Health. 2024;24(1):2979.","journal-title":"BMC Public Health"},{"key":"22188_CR21","doi-asserted-by":"crossref","unstructured":"Paik JM, et al. The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019. Hepatol Commun. 2023;7(10).","DOI":"10.1097\/HC9.0000000000000251"},{"key":"22188_CR22","doi-asserted-by":"publisher","first-page":"e4794","DOI":"10.7717\/peerj.4794","volume":"6","author":"XA Harrison","year":"2018","unstructured":"Harrison XA, et al. A brief introduction to mixed effects modelling and multi-model inference in ecology. PeerJ. 2018;6:e4794.","journal-title":"PeerJ"},{"issue":"1","key":"22188_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41598-020-79779-w","volume":"11","author":"L Chonco","year":"2021","unstructured":"Chonco L, Landete-Castillejos T, Serrano-Heras G, et al. Anti-tumour activity of deer growing antlers and its potential applications in the treatment of malignant gliomas. Sci Rep. 2021;11(1):42. https:\/\/doi.org\/10.1038\/s41598-020-79779-w.","journal-title":"Sci Rep."},{"issue":"10258","key":"22188_CR24","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(20)30677-2","volume":"396","author":"SE Vollset","year":"2020","unstructured":"Vollset SE, et al. Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study. Lancet. 2020;396(10258):1285\u2013306.","journal-title":"Lancet"},{"issue":"1","key":"22188_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/1536867X1601600112","volume":"16","author":"O O'Donnell","year":"2016","unstructured":"O\u2019Donnell O, et al. conindex: Estimation of concentration indices. Stata J. 2016;16(1):112\u201338.","journal-title":"Stata J"},{"key":"22188_CR26","doi-asserted-by":"crossref","unstructured":"Mirabelli M, et al. Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases. Nutrients. 2020;12(4).","DOI":"10.3390\/nu12041066"},{"issue":"2","key":"22188_CR27","doi-asserted-by":"publisher","first-page":"108389","DOI":"10.1016\/j.jdiacomp.2022.108389","volume":"37","author":"Y Handelsman","year":"2023","unstructured":"Handelsman Y, et al. Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases. J Diabetes Complications. 2023;37(2):108389.","journal-title":"J Diabetes Complications"},{"key":"22188_CR28","doi-asserted-by":"publisher","first-page":"1291501","DOI":"10.3389\/fmed.2024.1291501","volume":"11","author":"M Habibullah","year":"2024","unstructured":"Habibullah M, et al. Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies. Front Med (Lausanne). 2024;11:1291501.","journal-title":"Front Med (Lausanne)"},{"key":"22188_CR29","doi-asserted-by":"publisher","first-page":"155642","DOI":"10.1016\/j.metabol.2023.155642","volume":"146","author":"P Golabi","year":"2023","unstructured":"Golabi P, et al. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States. Metabolism. 2023;146: 155642.","journal-title":"Metabolism"},{"issue":"4","key":"22188_CR30","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/liv.15852","volume":"44","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Golabi P, Paik J, Owrangi S, Yilmaz Y, El-Kassas M, Alswat K, Alqahtani SA. Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver Int. 2024;44(4):1061\u201370.","journal-title":"Liver Int"},{"issue":"1","key":"22188_CR31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/hep.30625","volume":"70","author":"G Targher","year":"2019","unstructured":"Targher G, et al. Relationship Between PNPLA3 rs738409 Polymorphism and Decreased Kidney Function in Children With NAFLD. Hepatology. 2019;70(1):142\u201353.","journal-title":"Hepatology"},{"issue":"5","key":"22188_CR32","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.diabet.2019.01.011","volume":"45","author":"A Mantovani","year":"2019","unstructured":"Mantovani A, et al. Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease. Diabetes Metab. 2019;45(5):480\u20137.","journal-title":"Diabetes Metab"},{"issue":"1","key":"22188_CR33","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s11033-024-09787-w","volume":"51","author":"AA Husseini","year":"2024","unstructured":"Husseini AA. Genotypic variation in CYP2E1, GCKR, and PNPLA3 among nonalcoholic steatohepatitis patients of Turkish origin. Mol Biol Rep. 2024;51(1):845.","journal-title":"Mol Biol Rep"},{"key":"22188_CR34","doi-asserted-by":"publisher","first-page":"163406","DOI":"10.1016\/j.scitotenv.2023.163406","volume":"881","author":"G Wu","year":"2023","unstructured":"Wu G, et al. Ambient air pollution and incidence, progression to multimorbidity and death of hypertension, diabetes, and chronic kidney disease: A national prospective cohort. Sci Total Environ. 2023;881:163406.","journal-title":"Sci Total Environ"},{"key":"22188_CR35","doi-asserted-by":"publisher","unstructured":"Ferguson L, Taylor J, Davies M, Shrubsole C, Symonds P, Dimitroulopoulou S. Exposure to indoor air pollution across socio-economic groups in high-income countries: A scoping review of the literature and a modelling methodology. Environ Int. 2020;143:105748. https:\/\/doi.org\/10.1016\/j.envint.2020.105748.","DOI":"10.1016\/j.envint.2020.105748"},{"issue":"1","key":"22188_CR36","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1186\/s12889-024-19761-7","volume":"24","author":"X Kong","year":"2024","unstructured":"Kong X, et al. Associations of ambient air pollution and lifestyle with the risk of NAFLD: a population-based cohort study. BMC Public Health. 2024;24(1):2354.","journal-title":"BMC Public Health"},{"issue":"5","key":"22188_CR37","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S2542-5196(23)00053-0","volume":"7","author":"M Abbasi-Kangevari","year":"2023","unstructured":"Abbasi-Kangevari M, et al. GBD 2019 North Africa and the Middle East Air Pollution Collaborators. Effect of air pollution on disease burden, mortality, and life expectancy in North Africa and the Middle East: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Planet Health. 2023;7(5):e358\u201369.","journal-title":"Lancet Planet Health"},{"key":"22188_CR38","doi-asserted-by":"publisher","first-page":"204062232110486","DOI":"10.1177\/20406223211048649","volume":"12","author":"Y Cao","year":"2021","unstructured":"Cao Y, et al. The association between NAFLD and risk of chronic kidney disease: a cross-sectional study. Ther Adv Chronic Dis. 2021;12:20406223211048650.","journal-title":"Ther Adv Chronic Dis"},{"key":"22188_CR39","doi-asserted-by":"crossref","unstructured":"Seko Y, et al. FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease. Int J Mol Sci. 2019;21(1).","DOI":"10.3390\/ijms21010171"},{"issue":"1","key":"22188_CR40","doi-asserted-by":"publisher","first-page":"164","DOI":"10.14218\/JCTH.2021.00171","volume":"10","author":"Z Tao","year":"2022","unstructured":"Tao Z, et al. Influence of Nonalcoholic Fatty Liver Disease on the Occurrence and Severity of Chronic Kidney Disease. J Clin Transl Hepatol. 2022;10(1):164\u201373.","journal-title":"J Clin Transl Hepatol"},{"issue":"4","key":"22188_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41581-021-00519-y","volume":"18","author":"TY Wang","year":"2022","unstructured":"Wang TY, et al. Association of metabolic dysfunction-associated fatty liver disease with kidney disease. Nat Rev Nephrol. 2022;18(4):259\u201368.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"22188_CR42","doi-asserted-by":"publisher","first-page":"386","DOI":"10.21037\/hbsn-22-421","volume":"12","author":"DQ Sun","year":"2023","unstructured":"Sun DQ, et al. An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease. Hepatobiliary Surg Nutr. 2023;12(3):386\u2013403.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"3","key":"22188_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.hbpd.2023.08.004","volume":"23","author":"C Sun","year":"2024","unstructured":"Sun C, et al. Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int. 2024;23(3):241\u20138.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"3","key":"22188_CR44","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1016\/S2214-109X(23)00570-3","volume":"12","author":"AK Bello","year":"2024","unstructured":"Bello AK, et al. An update on the global disparities in kidney disease burden and care across world countries and regions. Lancet Glob Health. 2024;12(3):e382\u201395.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"22188_CR45","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.kisu.2024.01.003","volume":"13","author":"R Lowe-Jones","year":"2024","unstructured":"Lowe-Jones R, et al. Capacity for the management of kidney failure in the International Society of Nephrology North America and the Caribbean region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA). Kidney Int Suppl (2011). 2024;13(1):83\u201396.","journal-title":"Kidney Int Suppl (2011)"},{"key":"22188_CR46","doi-asserted-by":"publisher","unstructured":"Wing-Shing Fung W, Park HC, Hirakawa Y, et al. Capacity for the management of kidney failure in the International Society of Nephrology North and East Asia region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA). Kidney Int Suppl (2011). 2024;13(1):97\u2013109. https:\/\/doi.org\/10.1016\/j.kisu.2024.02.001.","DOI":"10.1016\/j.kisu.2024.02.001"},{"key":"22188_CR47","doi-asserted-by":"crossref","unstructured":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 2020. 396(10258): p. 1204\u20131222.","DOI":"10.1016\/S0140-6736(20)30925-9"},{"issue":"6","key":"22188_CR48","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrneph.2011.53","volume":"7","author":"DJ Goldsmith","year":"2011","unstructured":"Goldsmith DJ, Cunningham J. Mineral metabolism and vitamin D in chronic kidney disease\u2013more questions than answers. Nat Rev Nephrol. 2011;7(6):341\u20136.","journal-title":"Nat Rev Nephrol"},{"key":"22188_CR49","doi-asserted-by":"publisher","first-page":"117253","DOI":"10.1016\/j.bone.2024.117253","volume":"189","author":"J Li","year":"2024","unstructured":"Li J, Jia H, Liu Z, Xu K. Global, regional and national trends in the burden of low bone mineral density from 1990 to 2030: A Bayesian age-period-cohort modeling study. Bone. 2024;189:117253.","journal-title":"Bone"},{"issue":"2","key":"22188_CR50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1515\/fhep-2021-0035","volume":"24","author":"F Sanmarchi","year":"2021","unstructured":"Sanmarchi F, et al. Association between Economic Growth, Mortality, and Healthcare Spending in 31 High-Income Countries. Forum Health Econ Policy. 2021;24(2):101\u201318.","journal-title":"Forum Health Econ Policy"},{"key":"22188_CR51","doi-asserted-by":"crossref","unstructured":"Tan, M.P., Healthcare for older people in lower and middle income countries. Age Ageing. 2022;51(4).","DOI":"10.1093\/ageing\/afac016"},{"key":"22188_CR52","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"10355","key":"22188_CR53","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0140-6736(22)01441-6","volume":"400","author":"M Walli-Attaei","year":"2022","unstructured":"Walli-Attaei M, et al. Metabolic, behavioural, and psychosocial risk factors and cardiovascular disease in women compared with men in 21 high-income, middle-income, and low-income countries: an analysis of the PURE study. Lancet. 2022;400(10355):811\u201321.","journal-title":"Lancet"},{"issue":"5","key":"22188_CR54","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jhep.2024.01.014","volume":"80","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, et al. Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease. J Hepatol. 2024;80(5):694\u2013701.","journal-title":"J Hepatol"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22188-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-22188-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22188-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T13:49:42Z","timestamp":1741873782000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-22188-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22188"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-22188-3","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for this study in accordance with local\/national guidelines. Written informed consent to participate in the study was not required in accordance with local\/national guidelines. This study does not involve sensitive personal data, ethical issues, or breaches of policy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"993"}}